Inventor · disambiguated record
Haiying Sun
Also filed as: SUN HAIYING
11 granted patents·4 pending applications·147 citations·filing 2003–2022
90Inventor score
Top patents by PatentIndex Score
15 records- 0193US7932382B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Apr 26, 2011·17 cites·4 claims
- 0290US7674787B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Mar 9, 2010·16 cites·4 claims
- 0388US8445473B2Heteroaryl-substituted bicyclic Smac mimetics and the uses thereofWANG SHAOMENG·Filed 2009·Granted May 21, 2013·14 cites·3 claims
- 0487US7378403B2Akt inhibitors, pharmaceutical compositions, and uses thereofUS HEALTH·Filed 2003·Granted May 27, 2008·54 cites·54 claims
- 0586US7960372B2Bivalent Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2007·Granted Jun 14, 2011·14 cites·13 claims
- 0685US8278293B2Diazo bicyclic Smac mimetics and the uses thereofWANG SHAOMENG·Filed 2008·Granted Oct 2, 2012·10 cites·5 claims
- 0785US8202902B2Bivalent SMAC mimetics and the uses thereofWANG SHAOMENG·Filed 2008·Granted Jun 19, 2012·6 cites·4 claims
- 0880US7910621B2Small molecule antagonists of XIAP family proteinsUNIV MICHIGAN·Filed 2005·Granted Mar 22, 2011·5 cites·22 claims
- 0979US8883771B2Bivalent inhibitors of IAP proteins and therapeutic methods using the sameUNIV MICHIGAN·Filed 2013·Granted Nov 11, 2014·6 cites·22 claims
- 1079US8815927B2Bivalent diazo bicyclic Smac mimetics and the uses thereofWANG SHAOMENG·Filed 2010·Granted Aug 26, 2014·5 cites·3 claims
- 1156US2023088070A1Use of il-1beta binding antibodiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1251US8664212B2Diazo bicyclic Smac mimetics and the uses thereofWANG SHAOMENG·Filed 2012·Granted Mar 4, 2014·0 cites·5 claims
- 1349US2024327408A1Compounds containing tetrahydronaphthyridinone or tetrahydropyridopyrimidinone skeleton, preparation method therefor and pharmaceutical use thereofUNIV CHINA PHARMA·Filed 2022·Application pending·0 cites
- 1449US2023057071A1Combination of anti tim-3 antibody mbg453 and anti tgf-beta antibody nis793, with or without decitabine or the anti pd-1 antibody spartalizumab, for treating myelofibrosis and myelodysplastic syndromeNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1548US2020369762A1Use of il-1beta binding antibodiesNOVARTIS AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Haiying Sun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →